The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 112: Moderna's scant coronavirus data and the plight of the day trader
19 minutes
Posted May 21, 2020 at 8:10 pm.
0:00
19:24
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
When is a press release worth $5 billion? Can biotech stocks replace sports? And how will we know if a coronavirus vaccine actually works?
Previous
Episode 111: Covid-19 in the White House, a Parkinson’s experiment & public health lessons from porn
Next
Episode 113: Life after a coronavirus vaccine, virtual ASCO, and remembering Larry Kramer
← See all 424 episodes of The Readout Loud
